Nod2/CARD15 gene polymorphisms in idiopathic pulmonary fibrosis

Sarcoidosis Vasculitis and Diffuse Lung Diseases

Volumn 22, Issue 3, 2005, Pages 180-185

  Zorzetto, Michele ^a   Ferrarotti, Ilaria ^a   Campo, Ilaria ^a   Trisolini, Rocco ^b   Poletti, Venerino ^c   Scabini, Roberta ^a   Ceruti, Michele ^a   Mazzola, Paola ^a   Crippa, Elena ^a   Ottaviani, Stefania ^a   Agostini, Carlo ^d   Semenzato, Gianpietro ^d   Pozzi, Ernesto ^a   Luisetti, Maurizio ^a,e  

^a UNIVERSITY OF PAVIA   (Italy)

^b MAGGIORE HOSPITAL   (Italy)

^c MORGAGNI PIERANTONI HOSPITAL   (Italy)

^d UNIVERSITY OF PADOVA   (Italy)

^e FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Gene polymorphism; Innate immunity; Polymerase chain reaction; Sarcoidosis

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15;

ADULT; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; ETHNIC GROUP; FEMALE; GENE FREQUENCY; GENE FUNCTION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HUMAN; LUNG FIBROSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SARCOIDOSIS;

AGED; AMINO ACID SUBSTITUTION; DNA PRIMERS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOTYPE; HETEROZYGOTE DETECTION; HOMOZYGOTE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; ITALY; MALE; MIDDLE AGED; NOD2 SIGNALING ADAPTOR PROTEIN; POLYMORPHISM, SINGLE NUCLEOTIDE; PULMONARY FIBROSIS; REFERENCE VALUES; SARCOIDOSIS;

EID: 27944464958     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Gross TJ, Hunninghake GW: Idiopathic pulmonary fibrosis. N Engl J Med 2000; 345: 517-25.
2. Chung MP, Monick MM, Hamzeh NY, Butler NS, Powers LS, Hunninghake GW; Role of repeated lung injury and genetic background in bleomycin-induced fibrosis. Am J Respir Cell Mol Biol 2003; 29: 375-80.
3. du Bois RM, Kangesan I, Veeraraghavan S: Genetics of pulmonary fibrosis. Semin Respir Crit Care Med 2003; 24: 205-12.
4. Verleden GM, du Bois RM, Bouros D, et al: Genetic predisposition and pathogenetic mechanisms of interstitial lung diseases of unknown origin. Eur Respir J 2001; 32 (Suppl): 17s-29s.
5. Inohara N, Ogura Y, Chen FF, Muto A, Nuñez G: Human Nod1 confers responsiveness to bacterial lipopolysaccharides. J Biol Chem 2001; 276: 2551-4.
6. Lesage S, Zouali H, Cézard JP, et al: CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 2002; 70: 845-57.
7. Hugot JP, Chamaillard M, Zouali H, et al: Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001; 411: 599-603.
8. Ogura Y, Bonen DK, Inohara N, et al: A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001; 411: 537-9.
9. Hampe J, Cuthbert A, Croucher PJ, et al: Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet 2001; 357: 1925-8.
10. Girardin SE, Hogot J-P, Sansonetti PJ: Lessons from NOD2 studies: towards a link between Crohn's disease and bacterial sensing. Trends Immunol 2003; 24: 652-8.
11. Silverman EK, Palmer LJ: Case-control association studies for the genetics of complex respiratory disorders. Am J Respir Cell Mol Biol 2000; 22: 645-8.
12. American Thoracic Society: American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2002; 165: 277-304.
13. Zorzetto M, Ferrarotti I, Trisolini R, et al: Complement receptor 1 gene polymorphisms are associated with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2003; 168: 330-4.
14. Luisetti M, Beretta A, Casali L: Genetic aspects in sarcoidosis. Eur Respir J 2000; 16: 768-80.
15. Martinetti M, Luisetti M, Cuccia M: HLA and sarcoidosis: new pathogenetic insights. Sarcoidosis Vasc Diffuse Lung Dis 2002; 19: 83-95.
16. Schürmann M: Genetics of sarcoidosis. Semin Respir Crit Care Med 2003; 24: 213-21.
17. Grath DS, Goh N, Foley PJ, du Bois RM: Sarcoidosis: genes and microbes: soil or seed? Sarcoidosis Vasc Diffuse Lung Dis 2001; 18: 149-64.
18. Rybicki BA, Maliarik MJ, Bock CH, et al: The Blau syndrome gene is not a major risk factor for sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1999; 16: 203-8.
19. Schürmann M, Valentonyte R, Hampe J, Müller-Quernheim J, Schwinger E, Schreiber S: CARD15 gene mutations in sarcoidosis. Eur Respir J. 2003; 22: 748-54.
20. Zorzetto M, Bombieri C, Ferrarotti I, et al: Complement receptor I gene polymorphisms in sarcoidosis. Am J Respir Cell Mol Biol 2002; 27: 17-23.
21. Kobayashi K, Inohara N, Hernandez LD, et al: RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems. Nature 2002; 416: 194-9.
22. Gutierrez O, Pipaon C, Inohara N, et al: Induction of NOD2 in myelomonocytic and intestinal epithelial cells via nuclear factor-kB activation. J Biol Chem 2002; 277: 41701-5.
23. Ziegenhagen MW, Schrum S, Zissel G, Zipfel PF, Schlaak M, Müller-Quernheim J: Increased expression of proinflammatory chemokines in bronchoalveolar lavage cells of patients with progressing idiopathic pulmonary fibrosis and sarcoidosis. J Invest Med 1998; 46: 223-31.
24. Li J, Moran T, Swanson E, et al: Regulation of IL-8 and IL-1beta expression in Crohn's disease associated with NOD2/CARD15 mutations. Hum Mol Genet 2004; 13: 1715-25.
25. Heresbach, D, Gicquel-Douabin V, Birebent B, et al: NOD2/CARD15 gene polymorphisms in Crohn's disease: a genotype-phenotype analysis. Eur J Gastroenterol Hepatol 2004; 16: 55-62.
26. Girardin SE, Boneca IG, Viala J, et al: NOD2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem 2003; 278: 8869-72.
27. Selman M, Pardo A: Idiopathic pulmonary fibrosis: misunderstandings between epithelial cells and fibroblasts? Sarcoidosis Vasc Diffuse Lung Dis. 2004; 21: 165-72.
28. Antoniou KM, Alexandrakis MG, Sfiridaki K, et al: Th1 cytokine pattern (IL-12 and IL-18) in bronchoalveolar lavage fluid (BALF) before and after treatment with interferon gamma-1b (IFN-gamma-1b) or colchicines in patients with idiopathic pulmonary fibrosis (IPF/UIP). Sarcoidosis Vasc Diffuse Lung Dis 2004; 21: 105-10.
29. Beeh KM, Beier J, Kornmann O, Buhl R: Neutrophilic inflammation in induced sputum of patients with idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis 2003; 20: 138-43.
30. Inohara N, Ogura Y, Fontalba A, et al: Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J Biol Chem 2003; 278: 5509-12.
31. Whyte M, Hubbard R, Meliconi R, et al: Increased risk of fibrosing alveolitis associated with interleukin-1 receptor antagonist and tumor necrosis factor- gene polymorphisms. Am J Respir Crit Care Med 2002; 162: 755-8.
32. Hutirová B, Pantelidis P, Drábek J, et al: Interluekin-1 gene cluster polymorphisms in Sarcoidosis and idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2002; 165: 148-51.
33. Pantelidis P, Fanning GC, Wells AU, Welsh KI, du Bois RM: Analysis of tumor necrosis factor-α, lymphotoxin-α, tumor necrosis factor receptor II, and interleukin-6 polymorphisms in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2001; 163: 1432-6.
34. Thomas AQ, Lane K, Phillips J III, et al: Heterozygosity for a surfactant protein C gene mutation associated with usual interstitial pneumonias and cellular non-specific interstitial pneumonitis in one kindred. Am J Respir Crit Care Med 2002; 165: 1322-8.
35. 1 gene polymorphisms are associated with disease progression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2003; 168: 431-5.
36. Lawson WE, Grant SW, Ambrosini X et al: Genetic mutations in surfactant protein C are a rare cause of sporadic cases of IPF. Thorax 2004; 59: 977-80.
37. Selman M, Lin H-M, Montano M, et al: Surfactant protein A and B genetic variants predispose to idiopathic pulmonary fibrosis. Hum Genet 2003; 113: 542-50.
38. Bals R, Hiemstra PS. Innate immunity in the lung: how epithelial cells fight against respiratory pathogens. Eur Respir J 2004; 23: 327-33.
39. Xaubet A, Roca-Ferrer J, Pujols L, et al: Cyclooxygenase-2 is up-regulated in lung parenchyma of chronic obstructive pulmonary disease and down-regulated in idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis 2004; 21: 35-42.